Skip to content

TREO Abdominal Stent-Graft System 28-B2-26-100U (UDI 00843576152434)Recalls & reported problems

Bolton Medical Inc. · Endovascular Stent-Graft System · Class 3 · Implant

All models of TREO Abdominal Stent-Graft System (73)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00843576152434), received between Apr 7, 2025 and Feb 6, 2026 — classified as 1 injury, 2 malfunctions.

The most frequently reported specific device problem is “Deformation Due to Compressive Stress” (1 report).

1 other recall cover devices cleared under the same FDA submission (P190015); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 1 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 1 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Deformation Due to Compressive Stress1
  • Detachment of Device or Device Component1
  • Device Endoleak1
  • Failure to Seal1
  • Insufficient Device Problem Information1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3
  • Clinical Endoleak1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 6, 2026Insufficient Device Problem Information

    "BROKEN: AFTER THE MAIN BIFURCATED STENT-GRAFT WAS IMPLANTED, LEG STENT-GRAFTS (28-L2-20-120U, 28-L2-24-100U) WERE IMPLANTED WHILE LEAVING THE DELIVERY SHEATH OF THE MAIN BIFURCATED STENT-GRAFT. AT THAT TIME, A SCREW SCREWING THE PART THAT OPENS AND CLOSES THE MECHANICAL VALVE IN THE HUB OF THE SHEATH CAME OFF, WHICH MADE IT IMPOSSIBLE TO ADJUST THE VALVE. THE PROCEDURE WAS SUCCESSFULLY COMPLETED. NO BLOOD LOSS ANCILLARY DEVICES USED: 28-L2-20-120U, 28-L2-24-100U. IMAGE WILL BE ABLE TO BE OBTAINED PRE-CASE PLAN WILL BE ABLE TO BE OBTAINED ADDITIONAL INFORMATION WILL BE ABLE TO BE OBTAINED. ((B)(4) PATIENT OUTCOME: "NO HEALTH DAMAGE TO THE PATIENT."

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24283529 ↗
  • InjuryNov 4, 2025Detachment of Device or Device Component; Failure to Seal; Device Endoleak; Detachment of Device or Device Component; Failure to Seal; Device Endoleak

    "SUSPECTED TYPE 3B ENDOLEAK: ON (B)(6) 2025, THE TREO MAIN BIFURCATED STENT-GRAFT WAS SUCCESSFULLY IMPLANTED. HOWEVER, A FINAL ANGIOGRAM REVEALED ENDOLEAKS, WHICH DID NOT APPEAR TO BE TYPE 1A, 1B, OR TYPE 4. ADDITIONAL BALLOON MODELING WAS APPLIED, BUT ANGIOGRAPHY STILL SHOWED THE ENDOLEAKS PERSISTED. SUSPECTING A TYPE 2 ENDOLEAK DUE TO BLOOD FLOW FROM THE RIGHT IIA, BALLOON MODELING WAS APPLIED TO THE RIGHT CIA. ANGIOGRAPHY WAS THEN PERFORMED USING A PIGTAIL ANGIOGRAPHIC CATHETER FROM WITHIN THE STENT-GRAFT, YET ENTRY OF CONTRAST MEDIA INTO THE ANEURYSM WAS STILL OBSERVED. WHEN SELECTIVE ANGIOGRAPHY WAS PERFORMED USING THE ANGIOGRAPHIC CATHETER FROM INSIDE THE STENT-GRAFT TO THE AREA WITH DENSE CONTRAST WITHIN THE ANEURYSM, CONTRAST MEDIUM WAS OBSERVED ENTERING THE ANEURYSM AS IF BLOWING OUT FROM THE STENT-GRAFT, RAISING SUSPICION OF A TYPE 3B ENDOLEAK. TO TREAT THE SUSPECTED TYPE 3B ENDOLEAK, A 28 MM EXCLUDER CUFF STENT-GRAFT WAS PLACED WITHIN THE MAIN BIFURCATED STENT-GRAFT. RE-ANGIOGRAPHY REVEALED THAT THE ENDOLEAK HAD NOT RESOLVED. AS NO OTHER DEVICES WERE AVAILABLE FOR FURTHER INTERVENTION, THE PROCEDURE WAS TERMINATED. FURTHER TREATMENT OPTIONS WILL BE CONSIDERED AFTER FOLLO

    Patient problems: Clinical Endoleak; No Clinical Signs, Symptoms or Conditions

    MAUDE report 23463357 ↗
  • MalfunctionApr 7, 2025Deformation Due to Compressive Stress; Deformation Due to Compressive Stress

    "KINK IN THE STENT GRAFT: WHEN CANNULATION OF THE CONTRALATERAL GATE WAS TO BE INITIATED AFTER DEPLOYMENT OF THE CONTRALATERAL GATE OF THE MAIN BIFURCATED STENT GRAFT (28-B2-26-100U), A KINK WAS OBSERVED NEAR THE AREA BETWEEN THE SECOND AND THIRD STENTS. AN ATTEMPT WAS MADE TO RESOLVE THE KINK BY ADVANCING A GUIDEWIRE FROM THE CONTRALATERAL GATE TO THE CENTRAL SIDE OF THE STENT GRAFT AND INSERTING A BALLOON. HOWEVER, BECAUSE THE AREA BETWEEN THE SECOND AND THIRD STENTS WAS NOT ALMOST OPEN, AND THE DELIVERY SYSTEM WAS STILL PRESENT, THE GUIDEWIRE DID NOT ADVANCE TO THE CENTRAL PORTION DESPITE ATTEMPTS WITH A MICRO GUIDEWIRE AND A STIFF GUIDEWIRE. IT WAS DECIDED TO DEPLOY THE IPSILATERAL LEG AND RETRIEVE THE DELIVERY SYSTEM TIP FIRST AS THE NEXT STEP. WHEN THE DELIVERY SYSTEM TIP PASSED THROUGH THE OCCLUDED AREA WITH THE KINK, THE STENT GRAFT BEHAVED AS IF IT WAS BEING PULLED, BUT THE DELIVERY SYSTEM WAS SUCCESSFULLY REMOVED. (FINAL ANGIOGRAPHY AFTER THE PROCEDURE ALSO SHOWED THAT THERE WAS NO MIGRATION OF THE CENTRAL SIDE OF THE STENT GRAFT.) THE BALLOON WAS ADVANCED FROM THE IPSILATERAL LEG, THE KINKED PORTION WAS DILATED, AND THE KINK WAS RESOLVED. OPERATION TYPE: EVAR ANCILLARY D

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21785390 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P190015. One submission often covers many models, so check the product and lot details in each record.

  • Z-1689-2023 · May 3, 2023 · Open, Classified
    The TREO ABDOMINAL STENT-GRAFT SYSTEM (TREO) consists of four types of implants, specifically a Main Bifurcated Stent-Graft, a Leg Extension Stent-Graft, a Proximal Cuff Stent-Graf

Other System, Endovascular Graft, Aortic Aneurysm Treatment devices

All System, Endovascular Graft, Aortic Aneurysm Treatment devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page